Decreased BDNF signalling in transgenic mice reduces epileptogenesis.
about
Altered morphology of hippocampal dentate granule cell presynaptic and postsynaptic terminals following conditional deletion of TrkBBrain-derived neurotrophic factorSpinal Plasticity and Behavior: BDNF-Induced Neuromodulation in Uninjured and Injured Spinal Cord2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structureDecreased CREB levels suppress epilepsyDegeneration and proliferation of astrocytes in the mouse dentate gyrus after pilocarpine-induced status epilepticusBrain-derived neurotrophic factor and epilepsy--a missing link?Localization of brain-derived neurotrophic factor to distinct terminals of mossy fiber axons implies regulation of both excitation and feedforward inhibition of CA3 pyramidal cellsBDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 miceEarly phase of plasticity-related gene regulation and SRF dependent transcription in the hippocampusExpansion of the dentate mossy fiber-CA3 projection in the brain-derived neurotrophic factor-enriched mouse hippocampus.Methionine increases BDNF DNA methylation and improves memory in epilepsy.Aging-induced Seizure-related Changes to the Hippocampal Mossy Fiber Pathway in Forebrain Specific BDNF Overexpressing MiceBrain-derived neurotrophic factor as a drug target for CNS disorders.Subarachnoid Hemorrhage Promotes Proliferation, Differentiation, and Migration of Neural Stem Cells via BDNF Upregulation.Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease.Conditional deletion of TrkC does not modify limbic epileptogenesisBDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation.BDNF-TrkB signaling pathway mediates the induction of epileptiform activity induced by a convulsant drug cyclothiazide.In vivo evidence that truncated trkB.T1 participates in nociception.Garcinol Upregulates GABAA and GAD65 Expression, Modulates BDNF-TrkB Pathway to Reduce Seizures in Pentylenetetrazole (PTZ)-Induced EpilepsyDisruption of normal cytoskeletal dynamics may play a key role in the pathogenesis of epilepsy.Use of growth factors for the treatment of Parkinson's disease.Excitotoxicity in the pathogenesis of autism.The role of transcription factors cyclic-AMP responsive element modulator (CREM) and inducible cyclic-AMP early repressor (ICER) in epileptogenesis.An overview of brain-derived neurotrophic factor and implications for excitotoxic vulnerability in the hippocampus.Enhanced mossy fiber sprouting and synapse formation in organotypic hippocampal cultures following transient domoic acid excitotoxicity.BDNF-TrkB signaling pathway is involved in pentylenetetrazole-evoked progression of epileptiform activity in hippocampal neurons in anesthetized rats.Activation of mTOR signaling pathway is secondary to neuronal excitability in a mouse model of mesio-temporal lobe epilepsy.Effects of single-dose neuropeptide Y on levels of hippocampal BDNF, MDA, GSH, and NO in a rat model of pentylenetetrazole-induced epileptic seizure.Modulation of c-Fos and BDNF protein expression in pentylenetetrazole-kindled mice following the treatment with novel antiepileptic compound HHL-6.Correlated stage- and subfield-associated hippocampal gene expression patterns in experimental and human temporal lobe epilepsy.Effect of different mild hypoxia manipulations on kainic acid-induced seizures in the hippocampus of rats.Neuropeptide Y delays hippocampal kindling in the rat.Association of BDNF Polymorphisms with the Risk of Epilepsy: a Multicenter Study.
P2860
Q24602513-EC9EF544-CDD0-4C05-894D-890CEDEEEA4BQ24647026-2513CE61-66A3-441F-8362-42C7272CC0E2Q28072591-9B90FDF8-2A68-494E-8C10-329FEF0E0B09Q28268494-DE6C6357-80A2-4C07-AC16-D5160B0EE0D8Q30577603-DED6A50A-655E-444A-83C4-59F3C47E6D59Q33877317-1E5DBB58-D985-4E4C-B2E2-9A9290FCC8DFQ33941260-EE2ABE96-6C3C-47EA-827F-53A5075A3972Q34314205-CFA591CD-FEC5-46E9-ACBE-192A626BAB27Q34338809-758E9C67-B41C-4604-9CFA-AECB0DD24D61Q34917978-E5B316E6-69BF-45E0-A5F6-CF61C1CAE882Q35073511-801C7693-B1FA-42A2-869A-9F64A3E17EE5Q35469615-5086A82E-0E3A-4102-9E2B-082B89C8798DQ35806798-49414E01-014B-4B09-8F9C-BABEC9F8C089Q35911108-74B5B6EA-B696-4C93-A08B-54BCB6CBC2FAQ36188501-AB8BA1B7-9433-41D9-8F1A-273FBFB8C176Q36364388-A051B019-2724-4BEC-A6AE-3F4A678D9C0BQ36374155-818AFC09-9B18-4B8B-926B-98EADD09A9F2Q37061555-8D66ECA3-25AA-4ED5-8A5F-39221340ED5CQ37323394-1C0C71B9-80CB-4183-8063-4AD857F807CFQ37422382-13D8D04A-15D1-496E-974F-EDC6CBF3CFD1Q37425994-443C65AC-F46A-4ED6-B28B-21455916EC80Q37476461-5DC04886-D43E-4B07-807A-A294BAB7739CQ37762259-C0224638-C570-4E95-A104-4650D794F3C6Q38052081-07F10FC6-FC78-4338-AA89-E7092281B2D8Q38262696-96DC1A44-00CA-4E67-BB85-028529E29AE9Q38585641-43C6DCE3-F4AB-44AC-B257-2039F20A2895Q39292803-28464252-0DFB-4975-91B5-DB931B8FE0FEQ39441266-396DA3A8-0AA1-49AE-8298-EEDDE09402AFQ41553148-1836418C-AC8D-4195-8D04-ECF8A7FDECB6Q41849424-674E943E-179B-4D9E-9E12-45B9EBFD045DQ41957846-F3FBD56B-D212-4D82-B030-86D6286C612CQ44680410-1A9AE1FE-CA63-47C1-9FED-BDFAEC9F6CCDQ45981395-DAC8FB59-E00D-4901-A063-42CC6B94D010Q48225445-889AC078-D433-4B88-9F0D-543102FB69E2Q48228611-70539A85-226D-485C-8869-8333B669DEF2
P2860
Decreased BDNF signalling in transgenic mice reduces epileptogenesis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Decreased BDNF signalling in transgenic mice reduces epileptogenesis.
@en
Decreased BDNF signalling in transgenic mice reduces epileptogenesis.
@nl
type
label
Decreased BDNF signalling in transgenic mice reduces epileptogenesis.
@en
Decreased BDNF signalling in transgenic mice reduces epileptogenesis.
@nl
prefLabel
Decreased BDNF signalling in transgenic mice reduces epileptogenesis.
@en
Decreased BDNF signalling in transgenic mice reduces epileptogenesis.
@nl
P2093
P2860
P1476
Decreased BDNF signalling in transgenic mice reduces epileptogenesis.
@en
P2093
Asla Pitkänen
Eija Koponen
Jari Nissinen
Sari Lähteinen
Tommi Saarelainen
P2860
P304
P356
10.1046/J.1460-9568.2002.01897.X
P407
P50
P577
2002-02-01T00:00:00Z